Overview

Detailed Summary

Sunrest Lifescience Limited specializes in marketing OTC generic pharmaceutical products across multiple states in India, such as Maharashtra and Gujarat.
The company recently transitioned from a private to a public entity, marking its ambition for growth and greater market penetration.
Their product portfolio is diverse, covering therapeutic areas like anti-bacterial, anti-diabetic, and nutraceuticals, signaling a broad customer reach.
Sunrest Lifescience relies on Trilend Pharmaceuticals for product manufacturing, emphasizing an integrated group approach to operations.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Market Cap: 19 Cr
Volatility: High Risk
P/E Ratio: 9.4
Industry P/E: 27.5
PEG Ratio: 0.3
P/B Ratio: 1.2
52W High: 61.00
52W Low: 29.55

Sales CAGR

1Y: 12.35%
3Y: 7.20%
5Y: 24.77%
10Y: —

Profit CAGR

1Y: 769.57%
3Y: 37.04%
5Y: 122.35%
10Y: —

ROE

TTM: 10.58%
3Y: 12.75%
5Y: 14.95%
10Y: —

ROCE

TTM: 11.64%
3Y: 15.04%
5Y: 15.63%
10Y: —

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
DPL	8.79	23 Cr	21.44	0.56	0.00	3.48	6.70	1.16
MONOPHARMA	12.35	22 Cr	7.06	0.70	0.00	2.67	6.38	0.70
PNTKYOR	34.06	21 Cr	40.55	2.09	0.00	7.06	7.06	2.60
SUNREST	44.00	19 Cr	9.44	1.16	0.00	10.58	11.64	3.48
NORRIS	14.01	14 Cr	-25.02	0.00	0.00	9.68	-17.74	-4.15
ORTINGLOBE	17.17	14 Cr	-15.47	10.66	0.00	-73.01	-42.20	-23.24
BERLDRG	18.73	9 Cr	624.33	1.00	0.00	2.47	7.06	0.06

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023
Sales	5.64
Expenses	4.64
Operating Profit	1.00
OPM %	17.73
Other Income	0.00
Interest	0.01
Depreciation	0.02
Profit Before Tax	0.97
Tax %	22.68
Net Profit	0.75
EPS in Rs	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	11	17	27	25	29	33
Expenses	11	17	26	22	29	30
Operating Profit	0.15	0.27	1.11	2.90	0.91	3.00
OPM %	1.39	1.62	4.13	11.79	3.08	9.06
Other Income	0.00	0.00	0.02	0.03	0.00	0.00
Interest	0.00	0.01	0.02	0.06	0.22	0.30
Depreciation	0.02	0.04	0.06	0.13	0.10	0.09
Profit Before Tax	0.14	0.22	1.05	2.74	0.59	2.61
Tax %	73.12	25.98	26.02	25.54	61.92	23.33
Net Profit	0.04	0.17	0.78	2.04	0.23	2.00
EPS in Rs	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.01	0.01	0.01	3.00	4.29	4.29
Reserves	0.12	0.28	1.06	0.11	9.89	12
Borrowings	2.27	2.32	3.24	2.14	6.16	6.16
Other Liabilities	3.85	6.87	8.71	11	4.81	13
Total Liabilities	6.25	9.48	13	17	25	35
Fixed Assets	0.03	0.15	0.47	0.35	0.26	1.32
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.02	0.02	5.52
Other Assets	6.22	9.33	13	16	25	28
Total Assets	6.25	9.48	13	17	25	35

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.90	0.15	-0.44	1.15	-15	1.43
Cash from Investing Activity	-0.01	-0.16	-0.36	-0.03	-0.01	-1.14
Cash from Financing Activity	1.11	0.04	0.90	-1.15	15	-0.30
Net Cash Flow	0.20	0.03	0.11	-0.03	-0.16	-0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Nov 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	69.91%	69.91%	69.91%	69.91%	69.91%	69.91%	53.50%	53.50%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	30.01%	30.09%	30.09%	30.09%	30.09%	30.09%	46.50%	46.50%
Total Shareholders	742	580	505	487	459	455	498	491

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Sunrest Lifescience Ltd

Sunrest Lifescience Ltd (SUNREST) is currently trading at 45.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sunrest Lifescience Limited specializes in marketing OTC generic pharmaceutical products across multiple states in India, such as Maharashtra and Gujarat. The company recently transitioned from a private to a public entity, marking its ambition for growth and greater market penetration. Their product portfolio is diverse, covering therapeutic areas like anti-bacterial, anti-diabetic, and nutraceuticals, signaling a broad customer reach. Sunrest Lifescience relies on Trilend Pharmaceuticals for product manufacturing, emphasizing an integrated group approach to operations.

Over the past 52 weeks, Sunrest Lifescience Ltd has traded between a low of ₹29.55 and a high of ₹61.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sunrest Lifescience Ltd has a market capitalization of approximately 18.88. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sunrest Lifescience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 9.44 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 18.88 Cr, Sunrest Lifescience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sunrest Lifescience Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sunrest Lifescience Ltd is 9.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Sunrest Lifescience Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Sunrest Lifescience Ltd

What is Sunrest Lifescience Ltd share price today?

What does Sunrest Lifescience Ltd do?

What is the 52-week high and low of Sunrest Lifescience Ltd?

What is the market capitalization of Sunrest Lifescience Ltd?

Should I consider investing in Sunrest Lifescience Ltd stock?

Is Sunrest Lifescience Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Sunrest Lifescience Ltd belong to and why does it matter?

What is the PE ratio of Sunrest Lifescience Ltd?

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Sunrest Lifescience Ltd

What is Sunrest Lifescience Ltd share price today?

What does Sunrest Lifescience Ltd do?

What is the 52-week high and low of Sunrest Lifescience Ltd?

What is the market capitalization of Sunrest Lifescience Ltd?

Should I consider investing in Sunrest Lifescience Ltd stock?

Is Sunrest Lifescience Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Sunrest Lifescience Ltd belong to and why does it matter?

What is the PE ratio of Sunrest Lifescience Ltd?

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist